Which investor invests in what?
Investors, grants, loans, accelerators and other funding for European startups, from idea to Series C. Every fact links to its source. Looking for investors that fit your startup? Get matched.
360 results
Ventech
RollingParis-headquartered venture capital firm investing in European early-stage tech companies across seed and Series A rounds, with additional pre-seed activity via AFI Ventures.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €500K–€5M
- Last verified
- Verified 7 Nov 2026
MTE
UncertainMedTech Entrepreneurs Management GmbH
MTE is a German venture capital firm investing €500k to €3m in European pre-seed and early-stage MedTech and digital health startups.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed
- Countries
- Any country
- Key fact
- Ticket €500K–€3M
- Last verified
- Verified 7 Nov 2026
Turbine Capital
UncertainTurbine Capital is a Swedish venture capital fund investing €300k–€1m in seed-stage deep tech startups across Sweden and the Nordics.
- Kind
- Venture capital
- Stages
- Seed
- Countries
- DK, FI, IS +2
- Key fact
- Ticket €300K–€1M
- Last verified
- Verified 7 Nov 2026
Defence Invest
UncertainEuropean venture capital firm investing in early-stage defence-first and dual-use technology startups, particularly those located near NATO's eastern flank.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Last verified
- Verified 7 Nov 2026
Apex Ventures
UncertainAPEX Ventures
Apex Ventures is an early-stage European venture capital fund investing in deep tech startups, backing founders in AI, robotics, energy transition, computing, medtech, and space.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €500K–€2.5M
- Last verified
- Verified 7 Nov 2026
CRB Health Tech
UncertainSpanish venture capital firm investing in health technologies, including biotech, medical devices, and digital health companies at Seed and Series A stages.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €500K–€1.5M
- Last verified
- Verified 7 Nov 2026
Primo Capital
RollingPrimo Capital operates Primo Space, a venture capital fund investing in early-stage startups across the space economy, including upstream, downstream, in-orbit logistics, and satellite analytics.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed · Series A · Series B
- Countries
- Any country
- Key fact
- Typical round €24M
- Last verified
- Verified 7 Nov 2026
Senovo
UncertainSenovo Capital Management GmbH
Senovo is an early-stage venture capital fund investing €1m–€5m in European B2B enterprise software companies at Seed and Series A stages.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €1M–€5M
- Last verified
- Verified 7 Nov 2026
RegenEra Ventures
UncertainGlobal venture capital firm investing in early-stage biotech startups focused on regenerative medicine and diseases of ageing, primarily leading or co-leading Seed and Series A rounds in Europe.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Last verified
- Verified 7 Nov 2026
CARMA FUND
RollingMunich-based venture capital firm investing in European early-stage life science and healthcare companies across therapeutics, medtech, diagnostics, and digital health.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed · Series A · Series B
- Countries
- Any country
- Last verified
- Verified 7 Nov 2026
Vendep Capital
RollingVendep Capital is an early-stage venture capital firm investing in B2B SaaS startups across the Nordic and Baltic regions, offering initial tickets from €100k up to €3m.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €100K–€3M
- Last verified
- Verified 7 Nov 2026
Seventure Partners
RollingParis-headquartered venture capital firm investing in life sciences, particularly microbiome innovations, digital health, medtech, foodtech, and industrial biotechnology.
- Kind
- Venture capital
- Stages
- Seed · Series A · Series B · Series C+
- Countries
- Any country
- Key fact
- Ticket €1M–€10M
- Last verified
- Verified 7 Nov 2026
Helantic
UncertainEuropean venture capital firm investing €1m–€5m in early-stage defense and dual-use deeptech startups across DACH, CEE, and Nordics, focusing on autonomy, AI, space, and cybersecurity.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €1M–€5M
- Last verified
- Verified 7 Nov 2026
SCVC
RollingUK early-stage venture capital firm investing from pre-seed to Series A in deep tech startups, including quantum, biotech, AI, and advanced materials.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed · Series A
- Countries
- United Kingdom
- Last verified
- Verified 7 Nov 2026
Biovance Capital Partners
UncertainPortuguese life sciences VC investing in early-stage drug development and biotech startups across Europe, especially Southern Europe, targeting seed and Series A rounds.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €1.5M–€6M
- Last verified
- Verified 7 Nov 2026
Talos Global
UncertainTalos Global is a Munich-anchored venture capital fund investing at Seed and Series A stages in startups focused on Deep AI, enterprise automation, and autonomous decision systems globally.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Last verified
- Verified 7 Nov 2026
Steppe Ventures
UncertainEarly-stage VC investing €20k–€75k initial checks in European B2B software startups across Future of Work, FinTech, and Marketing Technology.
- Kind
- Venture capital
- Stages
- Pre-seed · Seed
- Countries
- Any country
- Key fact
- Ticket €20K–€75K
- Last verified
- Verified 7 Nov 2026
Alstin Capital
RollingAlstin Capital is a venture capital investor backing European B2B software companies at late seed and Series A stages, with initial investments ranging from €2m to €8m.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €2M–€8M
- Last verified
- Verified 7 Nov 2026
3B Future Health Fund
Uncertain3B Future Health
Healthcare venture fund investing up to $12M in early-stage oncology and rare disease startups across Europe, the US, and Israel, typically entering at Series A or earlier.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- IL, US
- Key fact
- Ticket up to €12M
- Last verified
- Verified 7 Nov 2026
Vsquared Ventures
RollingMunich-based deep-tech VC backing fundamental technology breakthroughs like quantum, AI, space, robotics, and biotech with initial investments of €500k to €5M at Seed and Series A stages.
- Kind
- Venture capital
- Stages
- Seed · Series A
- Countries
- Any country
- Key fact
- Ticket €500K–€5M
- Last verified
- Verified 7 Nov 2026